These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 29044542)
1. Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgery. Matsuo K; Johnson MS; Im DD; Ross MS; Bush SH; Yunokawa M; Blake EA; Takano T; Klobocista MM; Hasegawa K; Ueda Y; Shida M; Baba T; Satoh S; Yokoyama T; Machida H; Ikeda Y; Adachi S; Miyake TM; Iwasaki K; Yanai S; Takeuchi S; Nishimura M; Nagano T; Takekuma M; Shahzad MMK; Pejovic T; Omatsu K; Kelley JL; Ueland FR; Roman LD J Surg Oncol; 2018 Mar; 117(3):488-496. PubMed ID: 29044542 [TBL] [Abstract][Full Text] [Related]
2. A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma. Makker V; Abu-Rustum NR; Alektiar KM; Aghajanian CA; Zhou Q; Iasonos A; Hensley ML Gynecol Oncol; 2008 Nov; 111(2):249-54. PubMed ID: 18755503 [TBL] [Abstract][Full Text] [Related]
3. Paclitaxel and carboplatin in patients with completely or optimally resected carcinosarcoma of the uterus: a phase II trial by the Japanese Uterine Sarcoma Group and the Tohoku Gynecologic Cancer Unit. Otsuki A; Watanabe Y; Nomura H; Futagami M; Yokoyama Y; Shibata K; Kamoi S; Arakawa A; Nishiyama H; Katsuta T; Kudaka W; Shimada M; Sato N; Kotera K; Katabuchi H; Yaegashi N Int J Gynecol Cancer; 2015 Jan; 25(1):92-7. PubMed ID: 25347097 [TBL] [Abstract][Full Text] [Related]
4. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study. Guttmann DM; Li H; Sevak P; Grover S; Jacobson G; Feldman A; Rubin S; Chu C; Bhatia S; Elshaikh MA; Lin LL Int J Gynecol Cancer; 2016 Jan; 26(1):141-8. PubMed ID: 26509850 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy in uterine carcinosarcoma: Comparison of a doublet and a triplet chemotherapeutic regimen. Maheshwari U; Rajappa SK; Talwar V; Goel V; Dash PK; Sharma M; Goyal P; Jain P; B Koyyala VP; Doval DC Indian J Cancer; 2021; 58(2):179-184. PubMed ID: 33753600 [TBL] [Abstract][Full Text] [Related]
6. Carboplatin-Paclitaxel versus Cisplatin-Ifosfamide in the treatment of uterine carcinosarcoma: a retrospective cohort study. Lorusso D; Martinelli F; Mancini M; Sarno I; Ditto A; Raspagliesi F Int J Gynecol Cancer; 2014 Sep; 24(7):1256-61. PubMed ID: 25078338 [TBL] [Abstract][Full Text] [Related]
7. Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study. Powell MA; Filiaci VL; Rose PG; Mannel RS; Hanjani P; Degeest K; Miller BE; Susumu N; Ueland FR J Clin Oncol; 2010 Jun; 28(16):2727-31. PubMed ID: 20421537 [TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for Uterine Carcinosarcoma with Carboplatin, Ifosfamide and Mesna. Dandamudi RK; Aslam S; Walji N; El-Modir A; Fernando I Anticancer Res; 2015 Sep; 35(9):4841-7. PubMed ID: 26254376 [TBL] [Abstract][Full Text] [Related]
9. Prediction of Chemotherapy Response With Platinum and Taxane in the Advanced Stage of Ovarian and Uterine Carcinosarcoma: A Clinical Implication of In vitro Drug Resistance Assay. Matsuo K; Bond VK; Im DD; Rosenshein NB Am J Clin Oncol; 2010 Aug; 33(4):358-63. PubMed ID: 19875949 [TBL] [Abstract][Full Text] [Related]
10. A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma. Dickson EL; Vogel RI; Gehrig PA; Pierce S; Havrilesky L; Secord AA; Dottino J; Fader AN; Ricci S; Geller MA Gynecol Oncol; 2015 Nov; 139(2):275-82. PubMed ID: 26348313 [TBL] [Abstract][Full Text] [Related]
11. Treatment outcomes in completely resected stage I to stage IV uterine carcinosarcoma with rhabdomyosarcoma differentiation. Makker V; Kravetz SJ; Gallagher J; Orodel OP; Zhou Q; Iasonos A; DeLair D; Aghajanian C; Hensley ML Int J Gynecol Cancer; 2013 Nov; 23(9):1635-41. PubMed ID: 24172099 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma. Galaal K; van der Heijden E; Godfrey K; Naik R; Kucukmetin A; Bryant A; Das N; Lopes AD Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD006812. PubMed ID: 23450572 [TBL] [Abstract][Full Text] [Related]
13. Multimodality adjuvant therapy and survival outcomes in stage I-IV uterine carcinosarcoma. McEachron J; Heyman T; Shanahan L; Tran V; Friedman M; Gorelick C; Economos K; Singhal PK; Lee YC; Kanis MJ Int J Gynecol Cancer; 2020 Jul; 30(7):1012-1017. PubMed ID: 32447295 [TBL] [Abstract][Full Text] [Related]
14. Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma. Matsuo K; Omatsu K; Ross MS; Johnson MS; Yunokawa M; Klobocista MM; Im DD; Bush SH; Ueda Y; Takano T; Blake EA; Hasegawa K; Baba T; Shida M; Satoh S; Yokoyama T; Machida H; Adachi S; Ikeda Y; Iwasaki K; Miyake TM; Yanai S; Nishimura M; Nagano T; Takekuma M; Takeuchi S; Pejovic T; Shahzad MM; Ueland FR; Kelley JL; Roman LD Gynecol Oncol; 2017 Apr; 145(1):78-87. PubMed ID: 28215838 [TBL] [Abstract][Full Text] [Related]
15. Tumor characteristics and outcome of uterine carcinosarcoma in women aged ≥80 years. Matsuo K; Ross MS; Yunokawa M; Johnson MS; Machida H; Omatsu K; Klobocista MM; Im DD; Satoh S; Baba T; Ikeda Y; Bush SH; Hasegawa K; Blake EA; Takekuma M; Shida M; Nishimura M; Adachi S; Pejovic T; Takeuchi S; Yokoyama T; Ueda Y; Iwasaki K; Miyake TM; Yanai S; Nagano T; Takano T; Shahzad MM; Ueland FR; Kelley JL; Roman LD Surg Oncol; 2019 Jun; 29():25-32. PubMed ID: 31196490 [TBL] [Abstract][Full Text] [Related]
16. Salvage chemotherapy with taxane and platinum for women with recurrent uterine carcinosarcoma. Matsuo K; Ross MS; Yunokawa M; Johnson MS; Machida H; Omatsu K; Klobocista MM; Im DD; Satoh S; Baba T; Ikeda Y; Bush SH; Hasegawa K; Blake EA; Takekuma M; Shida M; Nishimura M; Adachi S; Pejovic T; Takeuchi S; Yokoyama T; Ueda Y; Iwasaki K; Miyake TM; Yanai S; Nagano T; Takano T; Shahzad MMK; Ueland FR; Kelley JL; Roman LD Gynecol Oncol; 2017 Dec; 147(3):565-571. PubMed ID: 29056442 [TBL] [Abstract][Full Text] [Related]
17. Paclitaxel-carboplatin for advanced or recurrent carcinosarcoma of the uterus: the Japan Uterine Sarcoma Group and Tohoku Gynecologic Cancer Unit Study. Takano T; Otsuki T; Tokunaga H; Toyoshima M; Utsunomiya H; Nagase S; Niikura H; Ito K; Yaegashi N; Yamada H; Tase T; Kagabu M; Shoji T; Sugiyama T; Sato N; Fujimoto T; Terada Y; Nakahara K; Kurachi H; Yokoyama Y; Mizunuma H; Soeda S; Nishiyama H; Matsumoto T; Sato S; Shimada M; Kigawa J Int J Clin Oncol; 2014 Dec; 19(6):1052-8. PubMed ID: 24395448 [TBL] [Abstract][Full Text] [Related]
18. Stage I uterine carcinosarcoma: Matched cohort analyses for lymphadenectomy, chemotherapy, and brachytherapy. Seagle BL; Kanis M; Kocherginsky M; Strauss JB; Shahabi S Gynecol Oncol; 2017 Apr; 145(1):71-77. PubMed ID: 28317560 [TBL] [Abstract][Full Text] [Related]
19. Comparison of first-line chemotherapy regimens for ovarian carcinosarcoma: a single institution case series and review of the literature. Brackmann M; Stasenko M; Uppal S; Erba J; Reynolds RK; McLean K BMC Cancer; 2018 Feb; 18(1):172. PubMed ID: 29426293 [TBL] [Abstract][Full Text] [Related]
20. A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus. Wolfson AH; Brady MF; Rocereto T; Mannel RS; Lee YC; Futoran RJ; Cohn DE; Ioffe OB Gynecol Oncol; 2007 Nov; 107(2):177-85. PubMed ID: 17822748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]